Movement disorders in Latin America

Parkinsonism and Related Disorders

Volumn 12, Issue 3, 2006, Pages 125-138

  Troiano, André R ^a   Micheli, Federico E ^b   Alarcón, Fernando ^c   Teive, Hélio A G ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c HOSPITAL EUGENIO ESPEJO   (Ecuador)

^d Neurology Service   (Brazil)

Author keywords

AIDS; Central America; Drug induced parkinsonism; HIV; Latin America; Manganese; Movement disorders; Neurocysticersosis; Secondary parkinsonism; South America; Spinocerebellar ataxias; Sydenham's chorea; Tuberculosis

Indexed keywords

AMIODARONE; AMLODIPINE; ANTIPARASITIC AGENT; ANTIPARKINSON AGENT; ATAXIN 1; ATAXIN 3; BENZATHINE PENICILLIN; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNARIZINE; FLUOXETINE; HALOPERIDOL; LEVODOPA; NEUROLEPTIC AGENT; PROPRANOLOL; QUININE; STEROID; TUBERCULOSTATIC AGENT; VALPROIC ACID; VERALIPRIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOREA MINOR; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG COST; DRUG INDUCED DISEASE; DRUG SAFETY; DYSTONIA; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ESSENTIAL TREMOR; GENETIC DISORDER; GILLES DE LA TOURETTE SYNDROME; HEAD INJURY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; IDIOPATHIC DISEASE; INFECTION; LIFESTYLE; MACHADO JOSEPH DISEASE; MALARIA; MENINGITIS; MOTOR DYSFUNCTION; NEUROCYSTICERCOSIS; OCCUPATIONAL DISEASE; PARASITOSIS; PARKINSON DISEASE; PARKINSONISM; PREVALENCE; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; SOUTH AMERICAN BLASTOMYCOSIS; SOUTH AND CENTRAL AMERICA; SPINOCEREBELLAR DEGENERATION; SUBACUTE SCLEROSING PANENCEPHALITIS; TARDIVE DYSKINESIA; TIC; TREMOR; TUBERCULOUS MENINGITIS;

HUMANS; LATIN AMERICA; MOVEMENT DISORDERS; PREVALENCE;

EID: 33646490557     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2005.08.009     Document Type: Review

References (147)

1. Kumar A. Movement disorders in the tropics. Parkinsonism Relat Disord 9 (2002) 69-75
2. Nicoletti A., Sofia V., Bartoloni A., Bartalesi F., Gamboa Barahon H., Giuffrida S., and Reggio A. Prevalence of Parkinson's disease: a door-to-door survey in rural Bolivia. Parkinsonism Relat Disord 10 (2003) 19-21
3. Melcon M.O., Anderson D.W., Vergara R.H., and Rocca W.A. Prevalence of Parkinson's disease in Junin, Buenos Aires Province, Argentina. Mov Disord 12 (1997) 197-205
4. Schonberg B.S., Anderson D.W., and Haerer A.F. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 35 (1985) 841-845
5. Schrag A. Epidemiology of movement disorders. In: Jankovic J., and Tolosa E. (Eds). Parkinson's disease and movement disorders. 4th ed (2002), Lippincott/Williams & Wilkins, Philadelphia, PA 73-89
6. Sanchez J.L., Buritica O., Pineda D., Uribe C.S., and Palacio L.G. Prevalence of Parkinson's disease and parkinsonism in a Colombian population using the capture-recapture method. Int J Neurosci 114 (2004) 175-182
7. Chouza C., Ketzoian C., Caamano J.L., Caceres R., Coirolo G., Dieguez E., and Rega I. Prevalence of Parkinson's disease in a population of Uruguay. Preliminary results. Adv Neurol 69 (1996) 13-17
8. Giroud Benitez J.L., Collado-Mesa F., and Esteban E.M. Prevalence of Parkinson's disease in an urban area of the Ciudad de La Habana province, Cuba: door-to-door population study. Neurologia 15 (2000) 269-273
9. Alarcón F., Cevallos N., and Lees A.J. Does combined levadopa and bromocriptine therapy in Parkinson's disease prevent late motor complications?. Eur J Neurol 5 (1998) 255-263
10. Cardoso F., Camargos S.T., and Silva Jr. G. Etiology of parkinsonism in a Brazilian movement disorders clinic. Arq Neuropsiquiatr 56 (1998) 171-175
11. Pineda D.A., Buritica O., Sanchez J.L., Uribe C.S., and Arana A. Parkinsonian syndromes in Medellin (Colombia). Rev Neurol 31 (2000) 936-943
12. Bower J.H., Maraganore D.M., McDonnell S.K., and Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 52 (1999) 1214-1220
13. Baldereschi M., Di Carlo A., Rocca W.A., Vanni P., Maggi S., Perissinotto E., Grigoletto F., Amaducci L., and Inzitari D. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 55 (2000) 1358-1363
14. Lucking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B.S., Meco G., Denefle P., Wood N.W., Agid Y., and Brice A. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 342 (2000) 1560-1567
15. Rawal N., Periquet M., Lohmann E., Lucking C.B., Teive H.A., Ambrosio G., Raskin S., Lincoln S., Hattori N., Guimaraes J., Horstink M.W., Dos Santos Bele W., Brousolle E., Destee A., Mizuno Y., Farrer M., Deleuze J.F., De Michele G., Agid Y., Durr A., Brice A., French Parkinson's Disease Genetics Study Group, and European Consortium on Genetic Susceptibility in Parkinson's Disease. New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. Neurology 60 (2003) 1378-1381
16. Periquet M., Latouche M., Lohmann E., Rawal N., De Michele G., Ricard S., Teive H., Fraix V., Vidailhet M., Nicholl D., Barone P., Wood N.W., Raskin S., Deleuze J.F., Agid Y., Durr A., Brice A., French Parkinson's Disease Genetics Study Group, and European Consortium on Genetic Susceptibility in Parkinson's Disease. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 126 (2003) 1271-1278
17. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., Fraix V., Broussolle E., Horstink M.W., Vidailhet M., Verpillat P., Gasser T., Nicholl D., Teive H., Raskin S., Rascol O., Destee A., Ruberg M., Gasparini F., Meco G., Agid Y., Durr A., Brice A., French Parkinson's Disease Genetics Study Group, and European Consortium on Genetic Susceptibility in Parkinson's Disease. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol 54 (2003) 176-185
18. Chaná P., and Galdames D. Accessibility to the specific pharmacotherapy for Parkinson disease, in Santiago de Chile. Rev Med Chil 126 (1998) 1355-1361
19. Andrade L.A., and Ferraz H.B. Idiopathic dystonia. Clinical profile of 76 Brazilian patients. Arq Neuropsiquiatr 50 (1992) 426-432
20. Igarreta P, Bertolini R, Herrera M, Micheli F, Bernath V. Estudio Genético para la Distonía de Torsión Primaria (DYT1), IV Congreso Latinoamericano de Movimientos Anormales. Punta del Este; 2004.
21. Ferraz H.B., and Andrade L.A. Symptomatic dystonia: clinical profile of 46 Brazilian patients. Can J Neurol Sci 19 (1992) 504-507
22. Fabiani G., Teive H.A.G., Germiniani F., Sa D., and Werneck L.C. Clinical and therapeutical features in 135 patients with dystonia: experience of movement disorders unit of the Hospital De Clinicas of Universidade Federal do Parana. Arq Neuropsiquiatr 57 (1999) 610-614
23. Alarcón F. Movimientos Involuntarios Anormales en Enfermedades Infecciosas. VIII Pan-American congress of neurology, Montevideo, Uruguay; 1991.
24. Teive H.A., Pereira E.R., Zavala J.A., Lange M.C., de Paola L., Raskin S., Werneck L.C., Hamada T., and McGrath J.A. Generalized dystonia and striatal calcifications with lipoid proteinosis. Neurology 63 (2004) 2168-2169
25. Micheli F., Pardal M.F., Gatto E., and Paradiso G. Dopa-responsive dystonia masquerading as idiopathic kyphoscoliosis. Clin Neuropharmacol 14 (1991) 367-371
26. Jalil P., Miranda M.C., and Frenkel C. Progressive hereditary dystonia with diurnal fluctuations: report of 2 cases. Rev Med Chil 121 (1993) 557-559
27. Cerosimo M.G., and Micheli F. Paroxysmal dyskinesia and gonadal sex hormones. Mov Disord 14 (1999) 876-877
28. Micheli F., Pardal M.F., Parera I.C., and Giannaula R. Sporadic paroxysmal dystonic choreoathetosis associated with basal ganglia calcifications. Ann Neurol 20 (1986) 750
29. Cosentino C., Torres L., Flores M., and Cuba J.M. Paroxysmal kinesigenic dystonia and spinal cord lesion. Mov Disord 11 (1996) 453-455
30. Andrade L.A., Borges V., Ferraz H.B., and Azevedo-Silva S.M. Botulinum toxin a: experience in the treatment of 115 patients. Arq Neuropsiquiatr 55 (1997) 553-557
31. Micheli F., Gatto E., Gershanik O., Steinschnaider A., Fernandez Pardal M.M., and Massaro M. Gilles de la Tourette syndrome: clinical features of 75 cases from Argentina. Behav Neurol 8 (1995) 75-80
32. Miranda M., Menendez P., David P., Troncoso M., Hernandez M., and Chaná P. Tics disease (Gilles de la Tourette syndrome): clinical characteristics of 70 patients. Rev Med Chil 127 (1999) 1480-1486
33. Cardoso F., Veado C.C., and de Oliveira J.T. A Brazilian cohort of patients with Tourette's syndrome. J Neurol Neurosurg Psychiatry 60 (1996) 209-212
34. Teive H.A., Germiniani F.M., Della Coletta M.V., and Werneck L.C. Tics and Tourette syndrome: clinical evaluation of 44 cases. Arq Neuropsiquiatr 59 (2001) 725-728
35. Alarcón F., and Lees A.J. Stuttering, tic-like facial movements and behavioural disorders. J Neurol 243 (1996) 105-106
36. Troiano A.R., Teive H.A., Fabiani G.B., Zavala J.A., Sa D.S., Germiniani F.M., Camargo C.H., and Werneck L.C. Clinical response to long action propranolol in 40 patients diagnosed with essential tremor with no previous treatment: an open, non-controlled study. Arq Neuropsiquiatr 62 (2004) 86-90
37. Diaz S., Scorticati M.C., and Micheli F. Hereditary chin tremor/myoclonus: a report from Latin America. Mov Disord 14 (1999) 180-182
38. Torres L., Velez M., and Cosentino C. Chin tremor in a Peruvian family. Rev Neurol 33 (2000) 958-959
39. Teive H.A.G., Iwamoto F.M., Camargo C.H.F., Della Colleta M.V., Germiniani F.M., Zanatta A., and Werneck L.C. Movement disorders in the tropics: a study of movement disorders secondary to infectious diseases in the south of Brazil. Neurology 56 (2001) A118-A119
40. Mattos J.P., Rosso A.L.Z., Correa R.B., and Novis S.A.P. Movement disorders in 28 HIV-infected patients. Arq Neuropsiquiatr 60 (2002) 525-530
41. Micheli F., Grañana N., Scorticati M.C., Giannaula R.J., and Reboredo G. Unilateral postural and action tremor resulting from thalamic toxoplasmosis in a patient with acquired immunodeficiency syndrome. Mov Disord 12 (1997) 1096-1098
42. Teive H.A., Troiano A.R., Cabral N.L., Becker N., and Werneck L.C. Hemichorea-hemiballism associated to cryptococcal granuloma in a patients with AIDS: case report. Arq Neuropsiquiatr 58 (2000) 965-968
43. Cardoso F. Infectious and transmissible movement disorders. In: Jankovic J., and Tolosa E. (Eds). Parkinson's disease and movement disorders. 4th ed (2002), Lippincott/Williams & Wilkins, Philadelphia, PA 584-595
44. Involuntary movement and bacterial meningitis. Lancet 1987;1:142-3.
45. Alarcón F., Duenas G., Cevallos N., and Lees A.J. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord 15 (2000) 561-569
46. Alarcón F, Narváez B. Desórdenes del movimiento en tuberculosis del sistema nervioso central. VII Congreso Ecuatoriano de Neurología, Quito; 1995.
47. Serrano-Dueñas M. Tuberculous meningitis and dystonia. Mov Disord 16 (2001) 582-583
48. Udani P.M., Parekh U.C., and Dastur D.K. Neurological and related syndromes in CNS tuberculoses: clinical features and pathogenesis. J Neurol Sci 14 (1971) 341-357
49. Dastur H.M. Tuberculomas. In: Vinken P.J., and Bruyn G.W. (Eds). Handbook of clinical neurology (1974), North-Holland, Amsterdam 413-426
50. Alarcón F. Movement disorders in 14 patients with cerebral tuberculomas. In: Parkinson's disease: new research. Marianne J. Willow, ed. New York: Nova Science Publishers, 2005.
51. Alarcón F., Calderón L., and Bara M.E. Manejo Médico de la Hidrocefalía Tuberculosa. Arch de Neurobiol Madrid 48 (1985) 133-136
52. Alarcón F., Tolosa E., and Muñoz E. Focal limb dystonia in a patient with a cerebellar mass. Arch Neurol 58 (2001) 1125-1127
53. Del Brutto O.H., Rajshekhar V., White Jr. A.C., Tsang V.C., Nash T.E., Takayanagui O.M., Schantz P.M., Evans C.A., Flisser A., Correa D., Botero D., Allan J.C., Sarti E., Gonzalez A.E., Gilman R.H., and Garcia H.H. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 (2001) 177-183
54. Trevisol-Bittencourt P.C., de Silva N.C., and Figueredo R. Prevalence of neurocysticercosis among epileptic in-patients in the west of Santa Catarina-southern Brazil. Arq Neuropsiquiatr 56 (1998) 53-58
55. De Souza Queiroz L., Filho A.P., Callegaro D., and De Faria L.L. Intramedullary cysticercosis. Case report, literature review and comment on pathogenesis. J Neurol Sci 26 (1975) 61-70
56. Cosentino C., Velez M., Torres L., and Garcia H.H. Cysticercosis lesions in basal ganglia are common but clinically silent. Clin Neurol Neurosurg 104 (2002) 57-60
57. Alarcón. Movement disorders in neurocysticercosis: report of 15 patients. In: Willow, Marianne J., editor, Parkinson's disease: new research. New York: Nova Science Publishers 2005.
58. Puri V., Chowdhury V., and Gulati P. Myoclonus: a manifestation of neurocysticercosis. Postgrad Med J 67 (1991) 68-69
59. Bhigjee A.I., Kemp T., and Cosnett J.E. Cerebral cysticercosis presenting with hemichorea. J Neurol Neurosurg Psychiatry 50 (1987) 1561-1562
60. Verma A., Berger J.R., Bowen B.C., and Sanchez-Ramos J. Reversible parkinsonian syndrome complicating cysticercus midbrain encephalitis. Mov Disord 10 (1995) 215-219
61. Keane J.R. Tremor as a result of shunt obstruction: four patients with cysticercosis and secondary parkinsonism: report of four cases. Neurosurgery 37 (1995) 520-522
62. Mathew I., and Hassa K.M. Neurocysticercosis presenting as reversible parkinsonian syndrome. J Assoc Physicians India 49 (2001) 288-289
63. Maitland K., Bejon P., and Newton C.R. Malaria. Curr Opin Infect Dis 16 (2003) 389-395
64. Roman G.C., and Senanayake N. Neurological manifestations of malaria. Arq Neuropsiquiatr 50 (1992) 3-9
65. Arya T.V., Awasthi R., and Bhutani J. Extrapyramidal syndrome in falciparum malaria. J Assoc Physicians India 37 (1989) 393-394
66. Pla M.P., Hartung C., Mendoza P., Stukanoff A., and Moreno M.J. Neuroparacoccidioidomycosis: case reports and review. Mycopathologia 127 (1994) 139-144
67. Bethlem E.P., Capone D., Maranhao B., Carvalho C.R., and Wanke B. Paracoccidioidomycosis. Curr Opin Pulm Med 5 (1999) 319-325
68. Nobrega J.P.S., and Spina-Franca A. Neuroparacoccidioidomycosis. In: Franco M., Lacaz C.S., Restrepo-Moreno A., and Del Negro G. (Eds). Paracoccidioidomycosis (1994), CRC Press, Boca Raton 321-330
69. Gasparetto E.L., Liu C.B., de Carvalho Neto A., and Rogacheski E. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr 27 (2003) 12-17
70. Teive H.A., Zanatta A., Germiniani F.M., Almeida S.M., and Werneck L.C. Holmes' tremor and neuroparacoccidioidomycosis: a case report. Mov Disord 17 (2002) 1392-1394
71. de Silva C.E., Cordeiro A.F., Gollner A.M., Cupolilo S.M., Quesado-Filgueiras M., and Curzio M.F. Paracoccidioidomycosis of the central nervous system: case report. Arq Neuropsiquiatr 58 (2000) 741-747
72. Cardoso F., Eduardo C., Silva A.P., and Mota C.C. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord 12 (1997) 701-703
73. Snider L.A., and Swedo S.E. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol 16 (2003) 359-365
74. Giedd J.N., Rapoport J.L., Kruesi M.J., Parker C., Schapiro M.B., Allen A.J., Leonard H.L., Kaysen D., Dickstein D.P., and Marsh W.L. Sydenham's chorea: magnetic resonance imaging of the basal ganglia. Neurology 45 (1995) 2199-2202
75. Cardoso F., Vargas A.P., Oliveira L.D., Guerra A.A., and Amaral S.V. Persistent Sydenham's chorea. Mov Disord 14 (1999) 805-807
76. Cardoso F., Maia D., Cunningham M.C., and Valenca G. Treatment of Sydenham chorea with corticosteroids. Mov Disord 18 (2003) 1374-1377
77. Silva R.J.M., Barbato Filho J.H., Correa Neto Y., and D'Avila U.J. Coreia de Sydenham: estudo clinico-evolutivo de 53 casos. Arq Catarin Med 17 (1988) 141-146
78. Terreri M.T.R.A., Roja S.C., Len C.A., Faustino P.C., Roberto A.M., and Hilario M.O.E. Sydenham's chorea: clinical and evolutive characteristics. Sao Paulo Med J 120 (2002) 16-19
79. Taratuto A.L., Piccardo P., Leiguarda R., Granillo R., Monti A., Scarlatti A., Leits A., Morasso C., Marquez Vigo C., and Vila J. Creutzfeldt-Jakob disease. Report of 10 neuropathologically-verified cases in Argentina. Medicina (B Aires) 49 (1989) 293-303
80. Galvez S., Cartier L., Monari M., and Araya G. Familial Creutzfeldt-Jakob disease in chile. J Neurol Sci 59 (1983) 139-147
81. Brown P., Galvez S., Goldfarb L.G., Nieto A., Cartier L., Gibbs Jr. C.J., and Gajdusek D.C. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 112 (1992) 65-67
82. Nitrini R., da Silva L.S.T., Rosemberg S., Caramelli P., Carrilho P.E.M., Iughetti P., Passos-Bueno M.R., Zatz M., Albrecht S., and LeBlanc A. Prion disease resembling frontotemporal dementia and parkinsonism linked to chromosome 17. Arq Neuropsiquiatr 59 (2001) 161-164
83. Nitrini R., Rosemberg S., Passos-Bueno M.R., da Silva L.S., Iughetti P., Papadopoulos M., Carrilho P.M., Caramelli P., Albrecht S., Zatz M., and LeBlanc A. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 42 (1997) 138-146
84. Garg R.K. Subacute sclerosing panencephalitis. Postgrad Med J 78 (2002) 63-70
85. Baczko K., Lampe J., Liebert U.G., Brinckmann U., Ter Meulen V., Pardowitz I., Budka H., Cosby S.L., Isserte S., and Rima B.K. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197 (1993) 188-195
86. Dyken P.R., Cunningham S.C., and Ward L.C. Changing character of subacute sclerosing panencephalitis in the United States. Pediatr Neurol 339 (1989) 339-341
87. Valenzuela C.V., Miranda Cabezas M., Aguilera O.L., Fabres O.L., and Galdames Poblete D. Adult onset subacute sclerosing panencephalitis: atypical presentation in 2 cases. Rev Med Chil 127 (1999) 589-594
88. Nunes M.L., Costa J.C., Stancher V.M., Diament A., Arita F., and Dyken P. Subacute sclerosing panencephalitis. Arq Neuropsiquiatr 57 (1999) 176-181
89. Krauss J.K., and Jankovic J. Head injury and posttraumatic movement disorders. Neurosurgery 50 (2002) 927-940
90. Krauss J.K., Trankle R., and Kopp K.H. Posttraumatic movement disorders in survivors of severe head injury. Neurology 47 (1996) 1488-1492
91. Weiner W.J. Can peripheral trauma induce dystonia? No!. Mov Disord 16 (2001) 13-22
92. Jankovic J. Can peripheral trauma induce dystonia and other movement disorders? Yes!. Mov Disord 16 (2001) 7-12
93. Jankovic J., and Van der Linden C. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry 51 (1988) 1512-1519
94. Nobrega J.C.M., Campos C.R., Limongi J.C.P., Teixeira M.J., and Lin T.Y. Movement disorders induced by peripheral trauma. Arq Neuropsiquiatr 60 (2002) 17-20
95. De Melo-Souza SE. Flunarizina, parkinsonismo e depressao. XI Brazilian neurology meeting, Goiania, Brazil; 1984.
96. Teive H.A., Troiano A.R., Germiniani F.M., and Werneck L.C. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord 10 (2004) 243-245
97. Micheli F., Romano E., Dominguez R., and Gatto E. Parkinsonism secondary to amiodarone therapy. Rev Neurol Argent 17 (1992) 56-58
98. Teive H.A., Germiniani F.M., and Werneck L.C. Parkinsonian syndrome induced by amlodipine: case report. Mov Disord 17 (2002) 833-835
99. Teive H.A.G., and Sa D.S. Worsening of parkinsonism after the use of veralipride for treatment of menopause: case report. Arq Neuropsiquiatr 59 (2001) 123-124
100. Gatto E.M., Fernandez Pardal M., and Micheli F. Parkinsonian aggravation from fluoxetine. Medicina (B Aires) 54 (1994) 182
101. Fontanari J.L. Residual tardive dyskinesia 24 months after suspension of flunarizine. Rev Bras Neurol 27 (1991) 97-98
102. Micheli F., Fernandez Pardal M.M., Gatto M., Asconapé J., Giannaula R., and Casas Parera I. Bruxism secondary to antidopaminergic drug exposure. Clin Neuropharmacol 16 (1993) 315-323
103. Cosentino C., Torres L., Scorticati M.C., and Micheli F. Movement disorders secondary to adulterated medication. Neurology 55 (2000) 598-599
104. Ferraz H.B., Andrade L.A., Tumas V., Calia L.C., and Borges V. Rural or urban living and Parkinson's disease. Arq Neuropsiquiatr 54 (1996) 37-41
105. Werneck A.L.S., and Alvarenga H. Genetics, drugs and environmental factors in Parkinson's disease. A case control study. Arq Neuropsiquiatr 57 (1999) 347-355
106. Huang C.C., Chu N.S., Lu C.S., Chen R.S., and Calne D.B. Long-term progression in chronic manganism: ten years of follow-up. Neurology 50 (1998) 698-700
107. Taranto A.J. Biological monitoring among workers exposed to manganese. Salud Ocup (B Aires) 16 (1998) 4-12
108. Perez Lucio, Villegas Rabling E.F., and Velez Zamora N.M. Chronic toxicity because of occupational exposure to manganese: report of four cases. Rev Med IMSS 36 (1998) 281-287
109. Mena I., Marin O., Fuenzalida S., and Cotzias G.C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17 (1967) 128-136
110. Olanow C.W., Good P.F., Shinotoh H., Hewitt K.A., Vingerhoets F., Snow B.J., Beal M.F., Calne D.B., and Perl D.P. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic and biochemical study. Neurology 46 (1996) 492-498
111. Ferraz H.B., Bertolucci P.H., Pereira J.S., Lima J.G., and Andrade L.A. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 38 (1988) 550-553
112. Barbosa E.R., Costa M.D.L., Bacheschi L.A., and Scaff M. Parkinsonism after glycine-derivate exposure. Mov Disord 16 (2001) 565-568
113. Gatto M., Fernandez Pardal M., Bagg E., Casas Parera I., and Micheli F. Parkinsonism after long term exposure to n-hexanes. Rev Neurol Argent 18 (1993) 26-27
114. Marchiori P.E., Barbosa E.R., Scaff M., Nitrini R., Midio A.F., and Assis J.L. Acute parkinson syndrome in intoxication due to organophosphate insecticides. Neurobiologia 47 (1984) 273-280
115. Alarcón F., and Cevallos N. Complicaciones del sistema nervioso central y periférico por ingesta de podofilina: reporte de dos casos. Rev Ecuat Neurol 5 (1996) 27-29
116. Caparros-Lefebvre D., and Elbaz A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet 354 (1999) 281-286
117. Caparros-Lefebvre D., Sergeant N., Lees A., Camuzat A., Daniel S., Lannuzel A., Brice A., Tolosa E., Delacourte A., and Duyckaerts C. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 125 (2002) 801-811
118. Champy P., Hoglinger G.U., Feger J., Gleye C., Hocquemiller R., Laurens A., Guerineau V., Laprevote O., Medja F., Lombes A., Michel P.P., Lannuzel A., Hirsch E.C., and Ruberg M. Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J Neurochem 88 (2004) 63-69
119. Lannuzel A., Michel P.P., Caparros-Lefebvre D., Abaul J., Hocquemiller R., and Ruberg M. Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe. Mov Disord 17 (2002) 84-90
120. Steele J.C., Caparros-Lefebvre D., Lees A.J., and Sacks O.W. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism. Parkinsonism Relat Disord 9 (2002) 39-54
121. Alarcon F., Zijlmans J.C., Duenas G., and Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 75 (2004) 1568-1574
122. Wolf P.A. Risk factors for stroke (editorial). Stroke 16 (1985) 359-360
123. Negrette A. Corea de Huntington: Estudio de Una Sola Familia a Traves de Varias Genereaciones (1955), Universidad de Zulia, Maracaibo, Venezuela
124. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., Watkins P.C., Ottina K., Wallace M.R., and Sakaguchi A.Y. A polymorphic DNA marker genetically linked to hntington's disease. Nature 306 (1983) 234-238
125. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
126. Cuba J.M., Castro C., and Benzaquen M. Sobre la epidemiología de la corea de huntington en el perú. Revista de NeuroPsiquiatría 46 (1983) 1-7
127. Cuba J.M. A focus of Huntington's chorea in Peru. Rev Neurol (Paris) 142 (1986) 151-153
128. Cuba J.M., and Torres L. Eight genealogic trees of families with Huntington's chorea in Canete (Peru). Rev Neurol (Paris) 145 (1989) 482-484
129. Pulst S.M. Inherited ataxias: an introduction. In: Pulst S.M. (Ed). Genetics of movement disorders (2003), Academic Press, Amsterdam 19-34
130. Ochoa-Morales A., and Alonso-Vilatela M.E. Psychosocial impact of ataxia. Arch Neurosci 6 (2001) 108-111
131. Silveira I., Lopes-Cendes I., Kish S., Maciel P., Gaspar C., Coutinho P., Botez M.I., Teive H., Arruda W., Steiner C.E., Pinto-Junior W., Maciel J.A., Jerin S., Sack G., Andermann E., Sudarsky L., Rosenberg R., MacLeod P., Chitayat D., Babul R., Sequeiros J., and Rouleau G.A. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology 46 (1996) 214-218
132. Lopes-Cendes I., Teive H., Calcagnotto M.E., Da Costa J.C., Cardoso F., Viana E., Maciel J.A., Radvany J., Arruda W., Trevisol-Bittencourt P.C., Rosa Neto P., Silveira I., Steiner C.E., Pinto Jr. W., Santos A.S., Correa Neto Y., Werneck L.C., Araujo A.Q., Carakushansky G., Mello L.R., Jardim L.B., Rouleau G.A., et al. Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a large group of Brazilian patients. Arq Neuropsiquiatr 55 (1997) 519-529
133. Teive H.A., Roa B.B., Raskin S., Fang P., Arruda W.O., Neto Y.C., Gao R., Werneck L.C., and Ashizawa T. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology 63 (2004) 1509-1512
134. Wadia N.H., and Swami R.K. A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain 94 (1971) 359-374
135. Burk K., Fetter M., Abele M., Laccone F., Brice A., Dichgans J., and Klockgether T. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2 and SCA3. J Neurol 246 (1999) 789-797
136. Velazquez-Perez L., Santos F.N., Garcia R., Paneque H.M., and Hechavarria P.R. Epidemiology of Cuban hereditary ataxia. Rev Neurol 32 (2001) 606-611
137. Velazquez-Perez L., Garcia R., Santos F.N., Paneque H.M., Medina H.E., and Hechavarria R.R. Hereditary ataxias in Cuba. Historical, epidemiological, clinical, electrophysiological and quantitative neurological aspects. Rev Neurol 32 (2001) 71-76
138. Velazquez-Perez L., Almader-Mederos L., Santos-Falcon N., Hechavarria-Pupo R., Sanchez-Cruz G., and Paneque-Herrera M. Spinocerebellar ataxia type 2 in Cuba. A study of the electrophysiological phenotype and its correlation with clinical and molecular variables. Rev Neurol 33 (2001) 1129-1136
139. Grewal R.P., Achari M., Matsuura T., Durazo A., Tayag E., Zu L., Pulst S.M., and Ashizawa T. Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10. Arch Neurol 59 (2002) 1285-1290
140. Matsuura T., and Ashizawa T. Spinocerebellar ataxia 10 (SCA10). In: Pulst S.M. (Ed). Genetics of movement disorders (2003), Academic Press, Amsterdam 103-116
141. Teive H.A.G., Ashizawa T., Roa B., Troiano A.R., Raskin S., Arruda W.O., and Werneck L.C. SCA10: description of 4 families with different phenotype. Neurology 60 (2003) A438
142. Igarreta P, Bertolini R, Herrera M, Bernath V. Análisis de la Frecuencia de las Ataxias SCA1, SCA2, SCA3 y SCA6 en individuos afectados de Ataxia Espinocerebelosa Autosómica Dominante de la Población Argentina. V Jornadas Nacionales de Neurología, Mar del Plata; 2003.
143. Velazquez-Perez L., Almaguer-Mederos L., Santos-Falcon N., Hechavarria R., Sanchez Cruz G., and Paneque H.M. Spinocerebellar ataxia type 2 in Cuba. A study of the electrophysiological phenotype and its correlation with clinical and molecular variables. Rev Neurol 33 (2001) 1129-1136
144. Ashizawa T., and Matsuura T. Spinocerebellar ataxia type 10 (SCA10): a disease caused by a novel pentanucleotide repeat expansion. Rinsho Shinkeigaku 41 (2001) 1120-1122
145. Lin X., and Ashizawa T. SCA10 and ATTCT repeat expansion: clinical features and molecular aspects. Cytogenet Genome Res 100 (2003) 184-188
146. Teive H.A., Roa B.B., Raskin S., Fang P., Arruda W.O., Neto Y.C., Gao R., Werneck L.C., and Ashizawa T. Clinical phenotype of Brazilian families with spinocerebellar atazia 10. Neurology 63 (2004) 1509-1512
147. Igarreta P, Bertolini R, HerreraM, Micheli F, Bernath V. Estudio Genético para la Distonía de Torsión Primaria (DYT1). IV Congreso Latinoamericano de Movimientos Anormales. Punta del Este, Uruguay; 2004.